Immuneering (IMRX) FCF Margin (2020 - 2022)
Immuneering's (IMRX) quarterly FCF Margin came in at 2597344.18% in Q4 2022, down 259246418.0% year-on-year from N/an in Q4 2021, and down 8949.64% quarter-over-quarter from 28701.08% in Q3 2022.
Immuneering (IMRX) FCF Margin (2020 - 2022) Analysis & Trends
Immuneering's FCF Margin history runs 3 years deep, the most recent figure standing at 2597344.18% for Q4 2022.
- On a quarterly basis, FCF Margin fell 259246418.0% year-over-year to 2597344.18% in Q4 2022; TTM through Sep 2023 was 10809489.45%, a 1080113559.0% decrease from a year earlier, with the FY2022 full-year figure at 14148.44%, down 1266227.0% from the prior year.
- FCF Margin declined to 2597344.18% in Q4 2022 per IMRX's latest filing, from 28701.08% in the prior quarter.
- Across five years, FCF Margin topped out at 511.54% in Q3 2020 and bottomed at 2597344.18% in Q4 2022.
- The 3-year median for FCF Margin is 3378.13% (2021), against an average of 265287.05%.
- Across the five-year window, FCF Margin sank 136471 bps in 2021 and plunged 259246418 bps in 2022, its largest moves.
- Year by year, FCF Margin stood at 825.64% in 2020, then tumbled by 491 bps to 4880.0% in 2021, then plunged by 53124 bps to 2597344.18% in 2022.
- Per Business Quant, the three latest IMRX FCF Margin figures stand at 2597344.18% (Q4 2022), 28701.08% (Q3 2022), and 10182.56% (Q2 2022).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 10.45% |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 43.35% |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 23.53% |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Immuneering | 279.33 Mn | 279.33 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | -2,597,344.18% |
| Sep 30, 2022 | -28,701.08% |
| Jun 30, 2022 | -10,182.56% |
| Mar 31, 2022 | -6,748.08% |
| Dec 31, 2021 | -4,880.00% |
| Sep 30, 2021 | -1,876.25% |
| Jun 30, 2021 | -978.31% |
| Mar 31, 2021 | -822.83% |
| Dec 31, 2020 | -825.64% |
| Sep 30, 2020 | -511.54% |